Quality

LifeNet Health’s tissue processing environment is designed to ensure allograft quality
 and safety. As both a medical device company and a tissue bank, we adhere to
 the highest standards of quality control, design control processes, and validation
 procedures. Our grafts consistently perform as expected, validated by internal
 assessments and recognized by healthcare organizations, industry partners, and
 regulatory bodies.

• Extraordinary Design Control Processes

• Validated Processes

• Quality Control Post-Processing Testing

• ISO, AATB, FDA, CLIA accreditations,
 registrations and certifications

Safety

Safety is paramount in everything we do. Since 1995, more than 11 million allografts
 processed using Allowash® technology have been distributed by LifeNet Health with
 no disease transmission. Our validated processes, quality systems, and technologies
 ensure patient safety, reducing the probability of infection that could be caused by an
 allograft implant. From stringent donor screening and review to controlled processing
 and terminal sterilization, every step of our donation process prioritizes safety.

Innovation

LifeNet Health is a leader in our industry, bringing clinicians, patients and researchers
 the most up-to-date solutions. LifeNet Health consistently provides the products,
 technologies, and services designed to improve safety, clinical effectiveness, ease of
 use and, ultimately, cost. Since opening its doors in 2012, the Institute of Regenerative
 Medicine has been a hub of research and development activity, dedicated to meeting clinical and scientific needs now — and in the future.